Effect of Mycophenolic Acid on Cyclosporin A-Induced Fibronectin Expression in Rat Mesangial Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Joon-Sung | - |
dc.contributor.author | Kim, Gheun-Ho | - |
dc.contributor.author | Jo, Chor Ho | - |
dc.contributor.author | Kim, Sua | - |
dc.contributor.author | Lee, Chang Hwa | - |
dc.contributor.author | Kim, Yong Soo | - |
dc.contributor.author | Kang, Chong Myung | - |
dc.date.accessioned | 2022-07-16T12:03:28Z | - |
dc.date.available | 2022-07-16T12:03:28Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0031-7012 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/163817 | - |
dc.description.abstract | This study was undertaken to determine if mycophenolic acid (MPA) inhibits the profibrotic action of cyclosporin A (CsA) and, if so, to determine the molecular mechanisms involved. The effect of MPA treatment on CsA-induced signaling through the transforming growth factor-beta (TGF-beta)/Smad pathway was evaluated by immunoblot analysis in cultured primary rat mesangial cells. Treatment of cells with 1 mu mol/l MPA did not significantly decrease the CsA-induced expression of TGF-beta(1), but partially reversed the increases in Smad3 phosphorylation and fibronectin (FBN) production, and increased Smad7 expression. These results suggest that MPA may ameliorate CsA-induced FBN production by modulating the Smad signaling pathway. This study provides evidence that MPA can attenuate CsA-induced renal injury after kidney transplantation. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KARGER | - |
dc.title | Effect of Mycophenolic Acid on Cyclosporin A-Induced Fibronectin Expression in Rat Mesangial Cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Joon-Sung | - |
dc.contributor.affiliatedAuthor | Kim, Gheun-Ho | - |
dc.contributor.affiliatedAuthor | Lee, Chang Hwa | - |
dc.identifier.doi | 10.1159/000343764 | - |
dc.identifier.scopusid | 2-s2.0-84868609179 | - |
dc.identifier.wosid | 000314794000004 | - |
dc.identifier.bibliographicCitation | PHARMACOLOGY, v.91, no.1-2, pp.20 - 28 | - |
dc.relation.isPartOf | PHARMACOLOGY | - |
dc.citation.title | PHARMACOLOGY | - |
dc.citation.volume | 91 | - |
dc.citation.number | 1-2 | - |
dc.citation.startPage | 20 | - |
dc.citation.endPage | 28 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | GROWTH-FACTOR-BETA | - |
dc.subject.keywordPlus | TGF-BETA | - |
dc.subject.keywordPlus | TRANSFORMING GROWTH-FACTOR-BETA-1 | - |
dc.subject.keywordPlus | GENE-THERAPY | - |
dc.subject.keywordPlus | FIBROSIS | - |
dc.subject.keywordPlus | SMAD7 | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | GLOMERULONEPHRITIS | - |
dc.subject.keywordPlus | NEPHROPATHY | - |
dc.subject.keywordPlus | KIDNEY | - |
dc.subject.keywordAuthor | Cyclosporin | - |
dc.subject.keywordAuthor | Fibrosis | - |
dc.subject.keywordAuthor | Transforming growth factor-beta | - |
dc.subject.keywordAuthor | Smad proteins | - |
dc.identifier.url | https://www.karger.com/Article/Abstract/343764 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.